Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study. (57/63)

Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma. (58/63)

Inhaler competence and patient satisfaction with Easyhaler(R): results of two real-life multicentre studies in asthma and COPD. (59/63)

Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study. (60/63)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis. (61/63)

Qualitative assessment of attributes and ease of use of the ELLIPTA dry powder inhaler for delivery of maintenance therapy for asthma and COPD. (62/63)

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD. (63/63)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8